Separation of Anticoagulants Using HALO® 90 Å C18, 2.0 μm
Bonded Phase: C18
Market Segment: Pharmaceuticals
Particle Size: 2 µm, 2.7 µm
Pore Size: 90 Å
Product Segment: SMALL MOLECULE
Separation Mode: Reversed Phase
USP Number: L1
Download File
Application Notes